|
|
|
|
|
|
|
|
|
|
|
|
 |
Jexys Pharmaceuticals Ltd.
|
|
Jexys is developing a platform of technologies for screening of new drugs using proprietary Mitogen Activated Protein Kinase MAPKs mutants isolated through molecular evolution. Jexys has already developed and patented active variants of MAPK enzymes that will serve as unequivocal targets for drug screening. Using the unique active MAPK enzymes Jexys has already developed high throughput screening systems in yeast. Jexys is screening its own libraries, but is interested also in collaborating and/or in providing screening services. |
|
Read More... |
|
KoVax Ltd.
|
 |
|
KoVax Ltd.’s objective is to conduct research that facilitates the development of effective vaccines in the Aqua culture world. The company manufactures and is the patent owner of KV3 vaccine against KHV for KOI and Common Carp. KoVax is the only company in the world that produces and markets an efficient and safe vaccine against KHV disease - KV3 Protect your fish with KV3 ELISA KIT. |
|
Read More... |
|
Leafsen Irrigation Systems Ltd.
|
 |
|
The mission of LeafSen Ltd. is to develop an irrigation system which will not only optimize the control of water flow in the field but also will feed the irrigation system the proper amount of water and/or fertilization level according to the physical condition of the irrigated crops. The product development follows an intensive research performed for several years. A study was made to characterize the need for water as a function of some physical, sensible attributes of the irrigated plant. The advantage of this idea relative to existing irrigation control system is that a Real Time evaluation is done by the system with regard to the necessity of water at the plant level ( "the end user"). |
|
Read More... |
|
MaimoniDex RA Ltd
|
 |
|
MaimoniDex RA will produce monoclonal antibodies aimed at eradicating or markedly reducing the destructive inflammatory activity in rheumatoid arthritis. The antibodies will be used to target and eliminate inflammatory cells, leaving cells engaged in normal biological functions undamaged |
|
Medgenics Inc.
|
 |
|
Medgenics is developing a breakthrough technology to fundamentally improve protein therapeutics. Medgenics’ unique platform technology promises a pipeline of ultra sustained action protein drugs - each replacing hundreds of injections used today. Medgenics technology is capable of offering treatment for a wide range of illnesses and conditions, including interferon-beta for multiple sclerosis, Factor VIII for hemophelia, and human growth hormone for stunted growth in children and to slow muscle atrophy in the elderly. |
|
Read More... |
|
MobilEye Vision Technologies Ltd.
|
 |
|
MobilEye was incorporated for the purpose of developing and marketing advanced products in the surging market of automated on-board driver assistant systems. The company has developed a number of proprietary algorithms and reference platforms that need only a single video camera for ACC, lane departure warning and collision mitigation. Multiple cameras are not needed for depth of scene calculation because MobilEye`s algorithms use an advanced spatio-temporal classification technique based on a novel machine learning approach that trains the system with static and dynamic visual information. |
|
Read More... |
|
Morria Biopharmaceuticals Inc.
|
 |
|
Morria Biopharmaceuticals is focusing on anti-inflammatory drugs. Morria is developing novel drugs for the treatment of a variety of acute and chronic inflammatory conditions including skin, lung and gastro-intestinal inflammatory diseases. |
|
Read More... |
|
MusicGenome Inc.
|
 |
|
MusicGenome developed a system for identifying musical taste, based on artificial intelligence. The analysis is done by using personal details and a personality questionnaire filled out by customers. The system enables music sites, companies and stores to offer titles suited to their taste. |
|
Read More... |
|
Nanonics Imaging Ltd.
|
 |
|
Nanonics is a market leader of combined near-field optical microscopes (NSOM) and atomic force microscopes (AFM). Nanonics is held by Nanoptics Ltd. |
|
Read More... |
|
Nasvax Ltd.
|
 |
|
NasVax develops innovative biopharmaceutical products improving the effectiveness or administration of vaccines. The company applies its platform technology to create adjuvant agents, which enhance the response of the body's immune system to vaccines, and produces needle-free, intranasal vaccine delivery vehicles. |
|
Read More... |
|
Novagali Pharma SA
|
 |
|
Novagali is a leader in the development of novel pharmaceutical products with technologies designed for intravenous, ocular, topical and oral delivery forms. The company's patented proprietary technology aims to improve the bioavailability and absorption of drugs while increasing safety and clinical efficacy, in particular for substances unsoluble in water commonly known as “lipophilic drugs” and large molecules. |
|
Read More... |
|
Novel Therapeutic Technologies (NTT) Ltd.
|
 |
|
Novel Therapeutic Technologies (NTT) develops a patented, passive, non-invasive, transdermal drug delivery system - The Ethosomes - capable to deliver safely and efficaciously active components through and across skin barriers in various semisolid dosage forms. |
|
Read More... |
|
NovoTyr Therapeutics Ltd.
|
|
NovoTyr is an Israeli biotechnology start-up established in March 2005 within the framework of the Israeli Chief Scientist incubator program. The company develop proprietary drugs which block the activity of selected tyrosine kinases in particular insulin-like growth factor receptor (IGF1R) “the target”. IGF1R, is a tyrosine kinases with a well established role in the development of cancer and non-malignant proliferative diseases like Psoriasis. In the last year NovoTyr successfully identified and characterize various hits from which it is now advancing its first anti-psoreasis “lead molecule” product for preclinical development and Phase I trial in Psoreasis. |
|
Read More... |
|
NutraLease Ltd.
|
 |
|
NutraLease has developed novel carriers for nutraceuticals to be incorporated in food systems and cosmetics formulations, increasing the bioavailability of the product. Some of the nutraceuticals incorporated in the carriers include lycopene, beta-carotene, lutein, phytosterols, CoQ10, lipoic acid, and DHA/EPA. Nutralease allows for the transport of compounds through biomembranes between the gut and the bloodstream, increasing bioavailability. NutraLease's carriers combine nano-sized, self-assemblies, and naturally occurring aggregated macromolecules dispersed in water with nutraceuticals. |
|
Read More... |
|
Protein Laboratories Rehovot (PLR) Ltd.
|
|
Protein Laboratories Rehovot (PLR) produces biologically active recombinant proteins (mainly different cytokines and their soluble receptors) in E. coli. PLR also has the know how to produce expression plasmids and recombinant proteins upon request. |
|
Read More... |
|
RavGalai Ltd
|
 |
|
Rav Galai is developing a simple to use system that enables rapid detection of residues of antibiotics in milk, meat and various food products. The kit will serve farms, dairy farms, food industry. The system is based on a biochemical reaction that is sensitive to antibiotics, and also to many other toxins. The system is designed as a simple-to-use kit, which does not require special equipment or identification tools. The kit is intended for use in any place and does not require special skills. The test results are received by the change in color on the back the special paper that constitutes part of the testing system. The kit is highly sensitive and is suited to food regulations. The technology is protected by two patents. |
|
ReadEasy Ltd.
|
 |
|
ReadEasy is developing a Natural Language Processing (NLP) based system that supplies the user with definitions and explanations to words and phrases according to the user’s level of knowledge in the subject matter and language of the desired text. |
|
Read More... |
|
Real-Time Radiography Inc.
|
 |
|
Real-Time Radiography develops a digital semiconductor detector using an X-ray photoconductor on top of a thin film transistor array for medical radiography, non-destructive testing and security applications. The technology enables improvements in development time and in resolution, high sensitivity, low cost electronics, as well as low voltage and reduced radiation to 1/10 of standard X-ray procedures. The flagship product, Filmless X-Ray (FXR) is the first implementation of the technology. Another product is a Flat Ceramic Detector (FCD), which is connected to the workstation and transfers the digital X-ray directly from the crystal. The plate is used for infinite re-photographing with no need for a connection to the X-ray machine itself, converting any existing X-ray machine to digital X-ray. Products in development include X-ray sensors and imaging sub-systems. |
|
Read More... |
|
SCT - Stem Cell Technology Ltd.
|
|
SCT Stem Cell Technology was formed for the purpose of conducting various research and commercial operations with the aim of developing hESC medical diagnostic and therapeutic products. The three initial points of focus are (i) research on liver cells, tissues and organs for the development of products for treating hepatic failure; (ii) research on pancreas cells, tissues and organs for the development of products for treating diabetes; and (iii) the development of a Universal Cell that will overcome cell rejection by patients. |
|
Sol-Gel Technologies Ltd.
|
 |
|
Sol-Gel develops products which enable the entrapment of organic and bioorganic molecules in glass by using a room-temperature chemical process. The initial application deals with a new formulation for existing chemical and physical sunscreens. |
|
Read More... |
|
|
|
|
|
|
 |
|
|
